Streetbeat News

Equity Actions

DRVN

Driven Brands has reaffirmed its fiscal year 2024 financial outlook, projecting revenues between $2.35 billion and $2.45 billion, which aligns with the $2.428 billion estimate. The company also expects its adjusted EPS to range from $0.88 to $1.00, closely matching the $0.95 estimate. Additionally, Driven Brands anticipates adjusted EBITDA to be between $535 million and $565 million.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:40 am

THRY

Thryv has announced the initiation of its first share repurchase program, committing to buy back up to $40 million of its shares. This move is aimed at returning value to shareholders and reflects the company's confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:34 am

BBIO

BridgeBio Pharma has launched BridgeBio Oncology Therapeutics (BBOT) with $200M in private external capital to advance clinical trials for treating RAS and PI3Kα pathway malignancies over the next 18-24 months.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:24 am

XYL

Xylem has updated its 2024 financial guidance, raising its adjusted EPS forecast to $4.10-$4.25 from the previous $4.00-$4.20 and its sales guidance to approximately $8.5 billion from $8.4-$8.5 billion. The company now anticipates a 15-16% increase in reported revenue and a 4-6% increase on an organic basis, with an adjusted EBITDA margin of about 20.0%.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:14 am

NVRI

Enviri (NVRI) updates its Q2 adjusted EPS forecast to $0.03 to $(0.05), against an estimated $0.01. For 2024, the adjusted EPS outlook is revised to $0.12 to $(0.09), including Harsco Rail, from a previous range of $(0.00) to $(0.25), excluding Harsco Rail.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:14 am

KIM

Kimco Realty has revised its FY24 financial outlook, lowering its FFO guidance from $1.56-$1.60 to $1.54-$1.58, below the $1.58 estimate. Conversely, EPS guidance was raised from $0.40-$0.44 to $0.47-$0.51.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:12 am

PTON

Peloton announced that CEO Barry McCarthy will step down, and Karen Boone and Chris Bruzzo will take over as Co-CEOs. This leadership change could signal a new strategic direction for Peloton.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:03 am

KTB

Kontoor Brands has updated its FY24 financial outlook, expecting revenue between $2.57B-$2.63B, with an adjusted EPS of $4.70-$4.80, up from the previous $4.65-$4.75 range. Adjusted gross margin is anticipated to be around 44.6%, and adjusted operating income is forecasted to be $377M-$387M. Cash from operations is expected to exceed $335M.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:54 am

ZOM

Zomedica has announced the issuance of three new patents, enhancing the intellectual property protection for its TRUFORMA diagnostic platform. This development could strengthen Zomedica's market position by safeguarding its proprietary technology, potentially leading to increased investor confidence and market competitiveness.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:41 am

RXO

RXO forecasts its Q2 adjusted EBITDA to be in the range of $24M-$30M and anticipates its brokerage gross margin to fall between 13%-15%.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:40 am